HORIZON_OLE
A single arm, multicenter, open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in participants who completed the parent Lp(a)HORIZON trial
- Stadium
- pijplijn
- Middel
- Populatie
- Primaire preventie coronairlijden
- Fase
- IIIb
- First Patient In
- -
- Last Patient In
- -
- Last Patient Last Visit
- -
Contact Bestuur
